decisionhealth Newsletters, Answer Books - 2007 Issue 10 (October)
National_Coverage_Determinations_Manual / Percutaneous Transluminal Angioplasty (PTA)
Subscribe or sign in to view the full article.
Article Overview
This article summarizes Medicare’s National Coverage Determination policy for percutaneous transluminal angioplasty and related stent procedures. It explains the general scope of the service, the categories of nationally covered indications, the circumstances involving carotid and intracranial artery interventions, and the facility standards, registry expectations, and recertification processes associated with covered carotid artery stenting services. It is relevant to hospital coders, vascular and interventional specialists, compliance teams, and reimbursement staff working with Medicare coverage policy.
Why This Topic Matters
The page helps readers understand when Medicare recognizes PTA-related services as covered versus noncovered under national policy and what administrative requirements apply to participating facilities. It is especially important for organizations that perform vascular, carotid, or intracranial stenting procedures and need to align documentation and facility processes with CMS coverage rules.
Article Sections
-
A. General
Provides a general overview of the procedure and its broad clinical use across vascular territories. It frames the policy context for the rest of the coverage determination.
-
B. Nationally Covered Indications
Describes the categories of situations in which the service is covered under Medicare policy. This section also addresses related carotid and intracranial stent coverage contexts, facility standards, registry participation, and recertification requirements.
-
C. Nationally Noncovered Indications
Summarizes categories of use that remain outside national coverage. It distinguishes excluded vascular indications from those addressed elsewhere in the policy.
-
D. Other
States the residual coverage position for indications not specifically addressed in the determination. This section closes the policy with a broad noncoverage statement.
What You Will Learn
- The general scope of CMS policy for PTA and related stent procedures
- Which major categories of vascular interventions are addressed in the coverage determination
- How carotid artery stenting coverage is tied to facility and registry requirements
- What kinds of administrative and documentation expectations apply to participating facilities
- Which broad categories of PTA use are treated as noncovered under national policy
Who Should Read This
- Medical coders
- Hospital compliance staff
- Revenue cycle teams
- Interventional radiology staff
- Vascular surgery teams
- Cardiology and neurointerventional staff
- Medicare reimbursement analysts
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com